Back to calendar
Actuate Therapeutics, Inc. (ACTU) Earnings
ACTU reports earnings on Wednesday, September 2, 2026
earnings report
September 2, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.20
Actual EPS: $-0.24
EPS surprise: 0.00%
Company overview
Market Cap$28.0M
PriceUSD 1.17
EPS (TTM)-0.99
52-week high9.22
52-week low1.03
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees12